Literature DB >> 28507086

The role and impact of cost-sharing mechanisms for prescription drug coverage.

Marc-André Gagnon1.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 28507086      PMCID: PMC5433868          DOI: 10.1503/cmaj.170169

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  Severity of illness and the welfare effects of moral hazard.

Authors:  Joseph G Eisenhauer
Journal:  Int J Health Care Finance Econ       Date:  2006-11-30

2.  The effects of catastrophic drug plan deductibles on older women's use of cardiovascular medicines: a retrospective cohort study.

Authors:  Steven G Morgan; Emilie J Gladstone; Deirdre Weymann; Nadia Khan
Journal:  CMAJ Open       Date:  2017-03-03

3.  Impact of income-based deductibles on drug use and health care utilization among older adults.

Authors:  Michael R Law; Lucy Cheng; Heather Worthington; Muhammad Mamdani; Kimberlyn M McGrail; Fiona K I Chan; Sumit R Majumdar
Journal:  CMAJ       Date:  2017-05-15       Impact factor: 8.262

4.  Adverse events associated with prescription drug cost-sharing among poor and elderly persons.

Authors:  R Tamblyn; R Laprise; J A Hanley; M Abrahamowicz; S Scott; N Mayo; J Hurley; R Grad; E Latimer; R Perreault; P McLeod; A Huang; P Larochelle; L Mallet
Journal:  JAMA       Date:  2001 Jan 24-31       Impact factor: 56.272

Review 5.  Pharmaceutical policies: effects of cap and co-payment on rational use of medicines.

Authors:  Vera Lucia Luiza; Luisa A Chaves; Rondineli M Silva; Isabel Cristina M Emmerick; Gabriela C Chaves; Silvia Cristina Fonseca de Araújo; Elaine L Moraes; Andrew D Oxman
Journal:  Cochrane Database Syst Rev       Date:  2015-05-08

6.  The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities.

Authors:  Xin Li; Daphne Guh; Diane Lacaille; John Esdaile; Aslam H Anis
Journal:  Health Policy       Date:  2006-11-28       Impact factor: 2.980

7.  Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.

Authors:  S B Soumerai; J Avorn; D Ross-Degnan; S Gortmaker
Journal:  N Engl J Med       Date:  1987-08-27       Impact factor: 91.245

8.  The impact of co-payment increases on dispensings of government-subsidised medicines in Australia.

Authors:  Anna Hynd; Elizabeth E Roughead; David B Preen; John Glover; Max Bulsara; James Semmens
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-11       Impact factor: 2.890

9.  Universal drug coverage and socioeconomic disparities in major diabetes outcomes.

Authors:  Gillian L Booth; Phoebe Bishara; Lorraine L Lipscombe; Baiju R Shah; Denice S Feig; Onil Bhattacharyya; Arlene S Bierman
Journal:  Diabetes Care       Date:  2012-08-13       Impact factor: 19.112

Review 10.  Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.

Authors:  Angela Acosta; Agustín Ciapponi; Morten Aaserud; Valeria Vietto; Astrid Austvoll-Dahlgren; Jan Peter Kösters; Claudia Vacca; Manuel Machado; Diana Hazbeydy Diaz Ayala; Andrew D Oxman
Journal:  Cochrane Database Syst Rev       Date:  2014-10-16
  10 in total
  4 in total

1.  Co-pay cards in Canada: Improving choice or institutionalizing bribes?

Authors:  Marc-André Gagnon
Journal:  CMAJ       Date:  2019-11-11       Impact factor: 8.262

2.  Capacity of Kidney Care in Canada: Identifying Barriers and Opportunities.

Authors:  Meaghan Lunney; Arian Samimi; Mohamad A Osman; Kailash Jindal; Natasha Wiebe; Feng Ye; David W Johnson; Adeera Levin; Aminu K Bello
Journal:  Can J Kidney Health Dis       Date:  2019-08-30

3.  Enhancing primary care capacity in chronic kidney disease management: a quality improvement educational initiative.

Authors:  Michelle D Smekal; Aminu K Bello; Maoliosa Donald; Deenaz Zaidi; Kerry McBrien; Katrina Nicholson; Ellen Novak; Brenda Hemmelgarn
Journal:  BMJ Open       Date:  2021-11-09       Impact factor: 3.006

4.  Cost-related medication nonadherence in Canada: a systematic review of prevalence, predictors, and clinical impact.

Authors:  Anne M Holbrook; Mei Wang; Munil Lee; Zhiyuan Chen; Michael Garcia; Laura Nguyen; Angela Ford; Selina Manji; Michael R Law
Journal:  Syst Rev       Date:  2021-01-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.